Vicky Pirzas is the SVP of Biopharmaceutical Product Development, responsible for recombinant, C&GT, mRNA and Vaccine development she has over 25 years of experience in the pharmaceutical and biological industry. She has held many different positions at CSL Limited, Glaxo, Soltec Research, RP Scherer, Sandoz and CSL Behring across the analytical and process development space in both small molecule and biologics development and held various leadership positions in Australia, Austria and Germany.She is highly experienced in activities associated with early development through to launch biopharmaceutical development, production scale-up, process characterization, Design of Experiment, process validation and Quality by Design.